Current Drug Safety
Title:Editorial ( Thematic Issue: Diabetes and Cancer - Disease, Drugs or Deception?)
Volume: 8 Issue: 5
Author(s): Peter Vestergaard
Affiliation:
Export Options
About this article
Cite this article as:
Vestergaard Peter, Editorial ( Thematic Issue: Diabetes and Cancer - Disease, Drugs or Deception?), Current Drug Safety 2013; 8 (5) . https://dx.doi.org/10.2174/1574886308999131206105822
DOI https://dx.doi.org/10.2174/1574886308999131206105822 |
Print ISSN 1574-8863 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3911 |
25
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Therapeutic Strategies for Targeting BRAF in Human Cancer
Reviews on Recent Clinical Trials Mitochondrial Dysfunction and Targeted Drugs: A Focus on Diabetes
Current Pharmaceutical Design Abatacept and Glomerular Diseases: The Open Road for the Second Signal as a New Target is Settled Down
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Tissue Engineering Techniques in Cardiac Repair and Disease Modelling
Current Pharmaceutical Design Patent Selections
Recent Patents on Biomarkers The Current Status of Cryotherapy and High-Intensity Focused UltraSound in the Treatment of Low-Grade Prostate Cancer
Reviews on Recent Clinical Trials Ultrasound Contrast Imaging in Cancer –Technical Aspects and Prospects
Current Molecular Imaging (Discontinued) Investigation on the Effects of Antimicrobial imidazo[2,1-b]thiazole Derivatives on the Genitourinary Microflora
Medicinal Chemistry Retinoids in Clinical Use
Medicinal Chemistry Synthesis and Biological Evaluation of 2-, 3-, and 4-Acylaminocinnamyl-Nhydroxyamides as Novel Synthetic HDAC Inhibitors
Medicinal Chemistry Disintegrins
Current Drug Targets - Cardiovascular & Hematological Disorders Clinical Proteomics in Cancer Research
Current Proteomics Multifunctional Anti-Cancer Nano-Platforms are Moving to Clinical Trials
Current Drug Metabolism The Function of the Selective Inhibitors of Cycloxygenase 2
Mini-Reviews in Medicinal Chemistry Cytotoxic Properties of Clofibrate and other Peroxisome Proliferators: Relevance to Cancer Progression
Current Medicinal Chemistry The Relevance of IgE in the Pathogenesis of Allergy: The Effect of an Anti-IgE Drug in Asthma and Other Diseases
Recent Patents on Inflammation & Allergy Drug Discovery The Potential for Targeting Oncogenic WNT/β -Catenin Signaling in Therapy
Current Drug Targets Teratogenic Toxicity Evaluation of Bladder Cancer-Specific Oncolytic Adenovirus on Mice
Current Gene Therapy TRP Channels and Pain
Current Pharmaceutical Design Lyn Regulates Cytotoxicity in Respiratory Epithelial Cells Challenged by Cigarette Smoke Extracts
Current Molecular Medicine